Phathom Pharmaceuticals, Inc. (PHAT) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$175.1M

Net Income/Loss (FY2025)

-$221.2M

Total Assets (FY2025)

$259.1M

Total Equity (FY2025)

-$438.2M

Cash Flows from Operating Activities (FY2025)

-$166.8M

Source: Phathom Pharmaceuticals, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.